Holen Sie sich die Stockscreener-App
255.43
0.61%
1.56
Handel nachbörslich:
255.43
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Gold Stevie Award for Employer of the Year – Jazz Pharmaceuticals - Oncodaily
Jazz Pharmaceuticals (JAZZ) Projected to Announce Earnings on Monday - MarketBeat
SummitTX Capital L.P. Reduces Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Castleark Management LLC Invests $9.21 Million in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC (JAZZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Cash Flow - TradingKey
Jazz Pharmaceuticals (JAZZ) Stock Still Looks Cheap As Shares Jumped 115% - simplywall.st
Jazz Pharmaceuticals plc Revenue Breakdown – NASDAQ:JAZZ - TradingView
TAK Stock Price and Chart — NYSE:TAK - TradingView
Renaissance Technologies LLC Sells 17,400 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
JAZZ|Jazz Pharmaceuticals PLC|Price:253.870|Chg%:-1.000 - TradingKey
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Aristotle Capital Management LLC - MarketBeat
Jazz Pharmaceuticals Reports Outcomes of 2026 Annual General Meeting with Strong Shareholder Backing - Kalkine Media
Jazz Pharmaceuticals held annual shareholder meeting in Dublin - Bitget
Is JAZZ Still the Best Cannabis Stock After Federal Rescheduling? - Yahoo Finance UK
Jazz Pharmaceuticals (NASDAQ: JAZZ) posts full 2026 AGM voting results - Stock Titan
Jazz Pharmaceuticals PLC $JAZZ is Systematic Financial Management LP's 5th Largest Position - MarketBeat
Jazz Pharmaceuticals PLC (JAZZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Jazz Pharmaceuticals plc (JAZZ) Stock Forecasts - Yahoo Finance
Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by Globeflex Capital L P - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Position Boosted by California Public Employees Retirement System - MarketBeat
Jazz Pharmaceuticals plc (JAZZ) stock price, news, quote and history - Yahoo Finance UK
SEB Asset Management AB Purchases New Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Jazz Pharmaceuticals stock hits all-time high at 250.85 USD By Investing.com - Investing.com Nigeria
Jazz Pharmaceuticals (NASDAQ:JAZZ) Hits New 52-Week High After Analyst Upgrade - MarketBeat
Jazz Pharmaceuticals stock hits all-time high at 250.85 USD - Investing.com
Will Jazz (JAZZ) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Principal Financial Group Inc. Increases Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals sets Aug. 3 webcast after market close - Stock Titan
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026 - PR Newswire UK
Needham & Company LLC Raises Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $282.00 - MarketBeat
JAZZ Maintains Buy Rating -- Price Target Raised to $282 by Need - GuruFocus
Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with a 5.74% Upside Potential - DirectorsTalk Interviews
Did Jazz’s Sleep and Oncology Pipeline Momentum Just Shift Jazz Pharmaceuticals' (JAZZ) Investment Narrative? - simplywall.st
Jazz Pharmaceuticals (JAZZ) Q1 2026 earnings summary - Quartr
Jazz Pharmaceuticals (JAZZ) Stock Still Looks Like A Bargain After A 119% Run - Yahoo Finance
Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Rating Upgraded by Canaccord Genuity Group - MarketBeat
Jazz Pharmaceuticals (JAZZ) Refocuses Its Sleep Franchise, Is The Stock Still Cheap? - Yahoo Finance
JAZZ Initiates Coverage On Canaccord Genuity -- Price Target Ann - GuruFocus
JAZZ Initiates Coverage On Canaccord Genuity -- Price Target Announces $290 - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Illinois Municipal Retirement Fund Acquires 13,057 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
JAZZ PHARMACEUTICALS PLC : CANACCORD GENUITY INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $290 - Bitget
Hsbc Holdings PLC Purchases Shares of 5,035 Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Is Jazz Pharmaceuticals (JAZZ) Still Undervalued On Its Oncology And Neuroscience Growth Story? - simplywall.st
JAZZ Maintains Overweight Rating by Barclays -- Price Target Raised to $260 - GuruFocus
JAZZ Maintained by Wells Fargo -- Price Target Raised to $285 - GuruFocus
Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Jazz Pharmaceuticals (JAZZ) Proxy filing Summary - Quartr
Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
JAZZ Maintained by Deutsche Bank -- Price Target Raised to $270 - GuruFocus
Jazz Patent Suit Over Xyrem Survives Dismissal In NJ - Law360
ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - TradingView
Jazz Pharmaceuticals (JAZZ) Q4 2025 earnings summary - Quartr
JAZZ Maintains Rating by Truist Securities -- Price Target Lowered to $254 - GuruFocus
Sleep Apnea Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Apnimed, Eli Lilly, Incannex Healthcare, Axsome Therapeutics, Jazz Pharma, Bioprojet - Barchart.com
Jazz Pharmaceuticals (JAZZ) director Cozadd sells 6,000 shares via 10b5-1 trade - Stock Titan
Jazz Pharmaceuticals Holds Steady Near Resistance as Volume Patterns Signal CautionQuality Factor - dars.gov.et
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):